...
首页> 外文期刊>BMJ Open >Chinese herbal medicine for patients with vascular cognitive impairment no dementia: protocol for a systematic review
【24h】

Chinese herbal medicine for patients with vascular cognitive impairment no dementia: protocol for a systematic review

机译:血管性认知功能障碍无痴呆患者的中草药:系统评价方案

获取原文
           

摘要

Introduction The aim of this systematic review is to assess the efficacy and safety of Chinese herbal medicine for the treatment of patients with vascular cognitive impairment but no dementia. Methods and analysis We will perform a comprehensive retrieval in the following electronic databases: PubMed, Cochrane Library, EMBASE, CINAHL, Chinese Biomedical Literature Service System (SinoMed), China National Knowledge Infrastructure (CNKI), Chinese Scientific Journals Database (VIP), Wan-fang database and other sources. After screening the studies, the methodological quality of all included trials will be assessed according to the risk of bias instrument provided by the Cochrane Collaboration. A meta-analysis of randomised controlled trials will be conducted using RevMan V.5.3 software. Funnel plot analysis and Egger's test will be used to assess publication bias, if possible. The quality of evidence will be assessed by the GRADE system. Dissemination This systematic review will be disseminated in a peer-reviewed journal and a relevant conference presentation. Trial registration number PROSPERO CRD 42015023682.
机译:引言本系统评价的目的是评估中草药治疗血管性认知功能障碍但无痴呆症的疗效和安全性。方法和分析我们将在以下电子数据库中进行全面检索:PubMed,Cochrane图书馆,EMBASE,CINAHL,中国生物医学文献服务系统(SinoMed),中国国家知识基础设施(CNKI),中国科学期刊数据库(VIP),万-fang数据库和其他来源。筛选研究后,将根据Cochrane合作组织提供的偏倚工具的风险评估所有纳入试验的方法学质量。将使用RevMan V.5.3软件进行随机对照试验的荟萃分析。如果可能,将使用漏斗图分析和Egger检验来评估发布偏倚。证据的质量将由GRADE系统评估。传播本系统评价将通过同行评审期刊和相关会议介绍进行传播。试用注册号PROSPERO CRD 42015023682。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号